Tdap Vaccination for Infant Caregivers

Sponsor

Yale University (Other)

Overall Status

Completed

CT.gov ID

NCT01233401

Collaborator

Saint Raphael Healthcare System (Other)

102

Enrollment

Location

Duration (Months)

8.5

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This study evaluates whether offering Tetanus, diphteria and acellular pertussis (Tdap) vaccine to caregivers of newborn infants during pediatric well child visits increase the caregivers' vaccination rates.

Condition or Disease	Intervention/Treatment	Phase
Pertussis Vaccination	Other: Survey

Study Design

Study Type:

Observational

Actual Enrollment :

102 participants

Observational Model:

Case-Only

Time Perspective:

Cross-Sectional

Official Title:

Tdap Vaccination for Infant Caregivers in the Pediatric Office

Study Start Date :

Jun 1, 2010

Actual Primary Completion Date :

Dec 1, 2010

Actual Study Completion Date :

Jun 1, 2011

Arms and Interventions

Arm	Intervention/Treatment
Mothers	Other: Survey Mothers and Other infant caregivers are surveyed at the end of the 2 week newborn well child visit about whether they chose to receive the Tdap vaccine at the pediatrician's office.
Other Infant Caregivers Includes fathers, grandparents, and other adults who are infant caregivers	Other: Survey Mothers and Other infant caregivers are surveyed at the end of the 2 week newborn well child visit about whether they chose to receive the Tdap vaccine at the pediatrician's office.

Arm

Intervention/Treatment

Mothers

Other: Survey

Mothers and Other infant caregivers are surveyed at the end of the 2 week newborn well child visit about whether they chose to receive the Tdap vaccine at the pediatrician's office.

Other Infant Caregivers

Includes fathers, grandparents, and other adults who are infant caregivers

Other: Survey

Mothers and Other infant caregivers are surveyed at the end of the 2 week newborn well child visit about whether they chose to receive the Tdap vaccine at the pediatrician's office.

Outcome Measures

Primary Outcome Measures

Maternal Tdap Vaccination Rate [At 2 week well child visit]

Secondary Outcome Measures

Other Infant Caregiver Tdap Vaccination Rate [At 2 week well child visit]

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years to 64 Years

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

18-64 years old
English or Spanish speaking

Exclusion Criteria:

Do not speak English or Spanish

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Hospital of St. Raphael	New Haven	Connecticut	United States	06511

Sponsors and Collaborators

Yale University
Saint Raphael Healthcare System

Investigators

Principal Investigator: Deepa R Camenga, MD, Yale University
Principal Investigator: Marjorie Rosenthal, MD MPH, Yale University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

, ,

ClinicalTrials.gov Identifier:

NCT01233401

Other Study ID Numbers:

1005006837

First Posted:

Nov 3, 2010

Last Update Posted:

Jul 28, 2011

Last Verified:

Jul 1, 2011

Keywords provided by , ,

Pertussis, Vaccination, Adult

Additional relevant MeSH terms:

Whooping Cough

Study Results

No Results Posted as of Jul 28, 2011